Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2555.95-35.95 (-1.39 %)
PREV CLOSE () 2591.90
OPEN PRICE () 2599.95
BID PRICE (QTY) 2556.90 (2)
OFFER PRICE (QTY) 2559.90 (1)
VOLUME 545
TODAY'S LOW / HIGH ()2535.95 2599.95
52 WK LOW / HIGH ()2022.05 3485.75
NSE2555.50-37.2 (-1.43 %)
PREV CLOSE() 2592.70
OPEN PRICE () 2585.10
BID PRICE (QTY) 2555.00 (1)
OFFER PRICE (QTY) 2555.50 (3)
VOLUME 19486
TODAY'S LOW / HIGH() 2534.70 2585.10
52 WK LOW / HIGH ()2111.05 3485
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director

Registered Office :

Address : Ajanta House,Charkop ,Kandivali (West),
Mumbai,
Maharashtra-400067

Phone : 022-66061000

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
12May Ajanta Pharma informs about annual sec
Ajanta Pharma has informed that it enclosed the copy of the Annual Secre..
05May Ajanta Pharma informs about written tr
Further to communication dated 30th April 2025 on earnings call, pursuan..
02May Ajanta Pharma informs about newspaper
Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has..
21Mar Ajanta Pharma to expand manufacturing
Ajanta Pharma is expanding its manufacturing capabilities by adding a st..
20Mar Ajanta Pharma informs about updates
Ajanta Pharma has informed that the Company is expanding its manufacturi..
Financials
in Millions
QTR Mar 25 ANNUAL 25
Net Profit1934.39168.9
Gross Profit 2281.5 11800.6
Operating Profit 2675.813245.9
Net Sales 10139.443220.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Glaxosmithkline Phar (BSE)
 2943.95 (5.51%)
M.Cap ( in Cr)
47266.82
Astrazeneca Pharma I (BSE)
 8248.60 (0.80%)
M.Cap ( in Cr)
20458.38
Neuland Laboratories (BSE)
 12651.00 (0.49%)
M.Cap ( in Cr)
16152.12
Divi's Lab (BSE)
 6126.90 (0.93%)
M.Cap ( in Cr)
161152.70
Sanofi Cons. Health (BSE)
 4925.20 (0.69%)
M.Cap ( in Cr)
11264.97
Shareholding Pattern
PROMOTERS 66.26%
MUTUAL FUNDS/UTI 15.13%
NON-INSTITUTION 7.39%
FI/BANKS/INSURANCE 1.58%
GOVERNMENT 0.01%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX81641.13492.91 (0.61%)
NIFTY24688.60110.25 (0.45%)
Dow Jones 42140.43-269.67 (-0.64%)
Nasdaq 19010.09301.75 (1.61%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI